MDiabetes: Advancing the journey of diabetes research and care
According to the Centers for Disease Control and Prevention, more than 100 million U.S. adults are now living with diabetes or prediabetes, and approximately 12.4 percent of the adult population in Michigan currently has the disease.
Michigan Medicine is a global leader when it comes to diabetes-related clinical care and investigation, with more than 250 faculty members dedicated to researching its causes and potential treatments.
In addition to this cohort of individual investigators, the institution has multiple nationally-funded programs that also support diabetes research. This is why the new Michigan Diabetes Center, or MDiabetes, was created.
“We are proud to announce the creation of MDiabetes, which will allow us to fully harness the diabetes-related strengths we have at Michigan Medicine, as well as create new opportunities in the realm of scientific discovery,” said Martin Myers, Jr., M.D., Ph.D., who serves as the director of the program.
Integrating science and care
MDiabetes aims to work across disciplines and programs to help integrate rigorous science with patient-centered care to prevent, treat and cure diabetes, its complications and related metabolic disorders.
Myers will work with an executive committee comprised of experts across a host of subject areas to lead the collaborative, which will run in conjunction with Michigan Medicine’s Brehm Center for Diabetes Research.
“We are very excited about this initiative,” said Myers. “The extensive diabetes research being accomplished here at Michigan Medicine already has a substantial impact, and MDiabetes will only help leverage this important work.”
MDiabetes will serve as the central hub to facilitate coordination among Michigan Medicine’s myriad diabetes-related programs, including those focused on type 1 and type 2 diabetes, obesity, metabolism and the complications associated with diabetes.
The initiative also seeks to support and expand existing areas of strength in diabetes-related research and will design and implement new programs throughout Michigan Medicine.
“One of our goals is to identify the needs among diabetes-related research programs to coordinate, build and support the common infrastructures that enhance synergies among these programs at Michigan Medicine,” said Dorene Markel, M.S., M.H.S.A, managing director of the program.
Anchored by scientists
MDiabetes will also coordinate training and enrichment programs for the diabetes research community, work with relevant departments and divisions to aid in the recruitment of new diabetes researchers, and help recruit, train and support clinical researchers who primarily focus on diabetes-related issues.
“Anchored by a group of more than 250 world-renowned, dynamic scientists with great expertise in diabetes, its complications and metabolism, MDiabetes will expedite Michigan Medicine’s quest for discovery and expand upon the breadth and depth of our abilities to impact diabetes research and care,” said Myers. “I am very proud of this exciting endeavor.”
To learn more about how the MDiabetes program will advance patient care, click here.